| Absorption |
| Blood-Brain Barrier | BBB+ | 0.6196 |
| Human Intestinal Absorption | HIA+ | 0.6091 |
| Caco-2 Permeability | Caco2- | 0.6654 |
| P-glycoprotein Substrate | Non-substrate | 0.6732 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9740 |
| Non-inhibitor | 0.9240 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8976 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8646 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8552 |
| CYP450 2D6 Substrate | Non-substrate | 0.8906 |
| CYP450 3A4 Substrate | Non-substrate | 0.7737 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9397 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9358 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9669 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9581 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9385 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9887 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9211 |
| Non-inhibitor | 0.9280 |
| AMES Toxicity | Non AMES toxic | 0.9224 |
| Carcinogens | Non-carcinogens | 0.8384 |
| Fish Toxicity | High FHMT | 0.7317 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.5413 |
| Honey Bee Toxicity | High HBT | 0.6009 |
| Biodegradation | Ready biodegradable | 0.9229 |
| Acute Oral Toxicity | III | 0.6695 |
| Carcinogenicity (Three-class) | Non-required | 0.7470 |